Can your own immune cells fight lung nodules?
NCT ID NCT07185035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether a patient's own natural killer (NK) cells, given as infusions, are safe and can help shrink lung nodules. 24 adults with high-risk nodules will receive multiple doses. The main goal is to check for side effects within 28 days, with tumor response as a secondary measure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous NK cells (KN5001)
- What this could lead to
- If it works, this could point toward a new way to shrink or control lung nodules without surgery.
- What could go wrong
- This is a very early, small trial (24 people) focused on safety. It may not show clear benefit, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY NODULES, MULTIPLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital with Nanjing Medical University
RECRUITINGNanjing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.